In order to contain expenditures for pharmaceuticals, the latest healthcare reforms have focused on decentralising …

This paper looks at the effects of WTO/TRIPS and pharmaceuticals on women. The focus is on the poor and women. The … benefits of health and modern pharmaceuticals. Access to generic low-priced medicines – including medicines for HIV AIDS …

competition on the optimal pricing strategies under a Reference Pricing Scheme (RPS). A two-stage model repeated infinite number … for competition. …

. Generic drugs might be a key driver of competition and cost containment in pharmaceutical markets. The dynamics of reforms of … long run benefits from fostering generic entry and post-patent competition into the markets. …

. Generic drugs might be a key driver of competition and cost containment in pharmaceutical markets. The dynamics of reforms of … long run benefits from fostering generic entry and post-patent competition into the markets. …

. The mergers and acquisitions process in the pharmaceutical industry is quite intense in Europe and in the USA, although in …

name pharmaceuticals, while the results regarding generics are less clear. In the empirical part of the paper, the … introduction of the substitution reform in the Swedish pharmaceuticals market in October 2002 is used as a natural experiment … lowered the price of both brand name- and generic pharmaceuticals. …

price of brand name pharmaceuticals, while the results regarding generics are less clear. In the empirical part of the paper …, the introduction of the substitution reform in the Swedish pharmaceuticals market in October 2002 is used as a natural … reform has lowered the price of both brand name- and generic pharmaceuticals. …